These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20381196)

  • 1. Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease.
    Cai G; Atzmon G; Naj AC; Beecham GW; Barzilai N; Haines JL; Sano M; Pericak-Vance M; Buxbaum JD
    Neurobiol Aging; 2012 Feb; 33(2):416-417.e3. PubMed ID: 20381196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 expression and promoter haplotype in Alzheimer's disease.
    Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
    Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between APP, ADAM10 gene polymorphism, and sporadic Alzheimer's disease in the Chinese population.
    Zeng F; Shen C; Liu YH; Li J; Zhu J; Wang YR; Yan JC; Gao CY; Zhou HD; Deng J; Wang YJ
    Neurotox Res; 2015 Apr; 27(3):284-91. PubMed ID: 25631235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.
    Kim M; Suh J; Romano D; Truong MH; Mullin K; Hooli B; Norton D; Tesco G; Elliott K; Wagner SL; Moir RD; Becker KD; Tanzi RE
    Hum Mol Genet; 2009 Oct; 18(20):3987-96. PubMed ID: 19608551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.
    Suh J; Choi SH; Romano DM; Gannon MA; Lesinski AN; Kim DY; Tanzi RE
    Neuron; 2013 Oct; 80(2):385-401. PubMed ID: 24055016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
    Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M
    Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population.
    Song JH; Yu JT; Liu M; Yan CZ; Tan L
    Brain Res; 2011 Nov; 1421():78-81. PubMed ID: 21959176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of Alzheimer disease.
    Tanzi RE
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.
    Augustin R; Endres K; Reinhardt S; Kuhn PH; Lichtenthaler SF; Hansen J; Wurst W; Trümbach D
    BMC Med Genet; 2012 May; 13():35. PubMed ID: 22594617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
    Prinzen C; Trümbach D; Wurst W; Endres K; Postina R; Fahrenholz F
    BMC Genomics; 2009 Feb; 10():66. PubMed ID: 19196476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM10 prodomain mutations cause late-onset Alzheimer's disease: not just the latest FAD.
    Vassar R
    Neuron; 2013 Oct; 80(2):250-3. PubMed ID: 24139026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.
    Lammich S; Buell D; Zilow S; Ludwig AK; Nuscher B; Lichtenthaler SF; Prinzen C; Fahrenholz F; Haass C
    J Biol Chem; 2010 May; 285(21):15753-60. PubMed ID: 20348102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
    Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
    J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.
    Deuss M; Reiss K; Hartmann D
    Curr Alzheimer Res; 2008 Apr; 5(2):187-201. PubMed ID: 18393804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
    Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
    Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Schroeder A; Fahrenholz F; Schmitt U
    J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
    Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
    FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.